Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SOLLAGEN
- Development stage
- Preclinical
- Lead developer
- CellResearch
- Modality
- Cell Therapies, Peptides, Recombinant Proteins and Enzymes, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Topical
01
Overview
SOLLAGEN is a topical cell therapy-derived product developed by CellResearch Corporation for the treatment of diabetic skin complications, particularly chronic diabetic foot ulcers (DFU). Its active ingredient, PTT-6®, is a proprietary complex containing over 3,000 proteins—including growth factors, cytokines, exosomes, glycoproteins, and peptides—derived from the culture media of umbilical cord lining stem cells. SOLLAGEN works by signaling local cells to regenerate, increasing cellular turnover, and stimulating the natural production of collagen, elastin, and hyaluronic acid. This multi-faceted approach accelerates wound repair, reduces inflammation, and promotes healing in refractory ulcers that have persisted for three months or longer.
- Brand names
- SOLLAGEN
- Other names
- SollagenPTT-6PTT6PTT 6
Beyond the preview
Go deeper on SOLLAGEN.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SOLLAGEN.